Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)
Clinical trial NCT05441826 · TERMINATED
Trial details
- NCT number
- NCT05441826
- Sponsor
- Tenet Medicines
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2023-05-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.